Divi’s Laboratories Stock Analysis
About Divi’s Laboratories
Divi’s Laboratories is a leading manufacturer of APIs and custom synthesis products for global pharmaceutical companies.
Business Model
- API manufacturing
- Custom synthesis
- Long-term supply contracts
Strengths
- Strong global client base
- High operating margins
- Strong export revenue
- Strong balance sheet
Risks
⚠ Dependence on export markets
⚠ Regulatory inspections
⚠ Customer concentration risk
Conclusion
Divi’s Laboratories is known for strong margins and export-driven business, though performance depends on global pharma demand cycles.